{"id":"https://openalex.org/W4403720786","doi":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc","title":"S2015 Cholangiocyte Response to Seladelpar Treatment","display_name":"S2015 Cholangiocyte Response to Seladelpar Treatment","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403720786","doi":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0001037428.45840.bc","doi":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Xia Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xia Wu","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077396900","display_name":"Yen\u2010Wen Chen","orcid":"https://orcid.org/0000-0001-7974-1132","observed_orcids":["https://orcid.org/0000-0001-7974-1132"]},"institutions":[{"id":"https://openalex.org/I4210138935","display_name":"Triple Ring Technologies (United States)","ror":"https://ror.org/04f33ym80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138935"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yen-Wen Chen","raw_affiliation_strings":["Triple Ring Technologies, Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Triple Ring Technologies, Newark, CA;","institution_ids":["https://openalex.org/I4210138935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052231696","display_name":"Jiangao Song","orcid":"https://orcid.org/0000-0002-7798-8868","observed_orcids":["https://orcid.org/0000-0002-7798-8868"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiangao Song","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060961843","display_name":"Edward E. Cable","orcid":"https://orcid.org/0000-0002-9268-968X","observed_orcids":["https://orcid.org/0000-0002-9268-968X"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward E Cable","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022177570","display_name":"Jeff D. Johnson","orcid":"https://orcid.org/0009-0001-9384-9577","observed_orcids":["https://orcid.org/0009-0001-9384-9577"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff D. Johnson","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joanne Elliott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138935","display_name":"Triple Ring Technologies (United States)","ror":"https://ror.org/04f33ym80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138935"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Elliott","raw_affiliation_strings":["Triple Ring Technologies, Newark, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Triple Ring Technologies, Newark, CA;","institution_ids":["https://openalex.org/I4210138935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061515333","display_name":"Francisco Javier Caballero-Camino","orcid":"https://orcid.org/0000-0002-6160-5906","observed_orcids":["https://orcid.org/0000-0002-6160-5906"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]},{"id":"https://openalex.org/I4210100188","display_name":"Biogipuzkoa Health Research Institute","ror":"https://ror.org/01a2wsa50","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210100188"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco J. Caballero-Camino","raw_affiliation_strings":["Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country, San Sebastian, Extremadura, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country, San Sebastian, Extremadura, Spain","institution_ids":["https://openalex.org/I169108374","https://openalex.org/I4210100188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100741539","display_name":"Xin Chen","orcid":"https://orcid.org/0000-0003-1563-5976","observed_orcids":["https://orcid.org/0000-0003-1563-5976"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Chen","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101556120","display_name":"Yun\u2010Jung Choi","orcid":"https://orcid.org/0000-0002-5153-9714","observed_orcids":["https://orcid.org/0000-0002-5153-9714"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun-Jung Choi","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Martin","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108813492","display_name":"Jeffrey W. Stebbins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Stebbins","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084083958","display_name":"Jes\u00fas M. Ba\u00f1ales","orcid":"https://orcid.org/0000-0002-5224-2373","observed_orcids":["https://orcid.org/0000-0002-5224-2373"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]},{"id":"https://openalex.org/I4210100188","display_name":"Biogipuzkoa Health Research Institute","ror":"https://ror.org/01a2wsa50","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210100188"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jesus M. Banales","raw_affiliation_strings":["Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country, San Sebastian, Extremadura, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country, San Sebastian, Extremadura, Spain","institution_ids":["https://openalex.org/I169108374","https://openalex.org/I4210100188"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044763036","display_name":"Charles A. McWherter","orcid":"https://orcid.org/0000-0002-7613-3008","observed_orcids":["https://orcid.org/0000-0002-7613-3008"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. McWherter","raw_affiliation_strings":["CymaBay, a Gilead Sciences Company, Fremont, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CymaBay, a Gilead Sciences Company, Fremont, CA;","institution_ids":["https://openalex.org/I4210140816"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210140816"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"119","issue":"10S","first_page":"S1441","last_page":"S1441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/seladelpar","display_name":"seladelpar","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cholangiocytes","display_name":"cholangiocytes","score":0.8410000205039978},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/ppardelta-agonist","display_name":"PPAR\u03b4 agonist","score":0.871999979019165},{"id":"https://openalex.org/keywords/h69-cells","display_name":"H69 cells","score":0.9259999990463257},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.9089999794960022},{"id":"https://openalex.org/keywords/il-31","display_name":"IL-31","score":0.6759999990463257},{"id":"https://openalex.org/keywords/bile-acid-metabolism","display_name":"bile acid metabolism","score":0.4690000116825104},{"id":"https://openalex.org/keywords/fatty-acid-beta-oxidation","display_name":"fatty acid beta-oxidation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/angptl4","display_name":"ANGPTL4","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pyruvate-dehydrogenase-kinase-4","display_name":"PDK4","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cholangiopathy","display_name":"cholangiopathy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.6729999780654907},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.3700000047683716},{"id":"https://openalex.org/keywords/translational-model","display_name":"translational model","score":0.6600000262260437},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9373939037322998},{"id":"https://openalex.org/C2780186670","wikidata":"https://www.wikidata.org/wiki/Q5104283","display_name":"Cholangiocyte","level":2,"score":0.7674526572227478},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24647793173789978}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0001037428.45840.bc","doi":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001037428.45840.bc","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415478064","https://openalex.org/W4399459829","https://openalex.org/W4291298104","https://openalex.org/W4394590038","https://openalex.org/W7221826020","https://openalex.org/W7221682965","https://openalex.org/W4388034582","https://openalex.org/W3193674176","https://openalex.org/W4408366701","https://openalex.org/W4413803152"],"abstract_inverted_index":{"Introduction:":[0],"Cholangiocytes":[1],"are":[2],"epithelial":[3],"cells":[4,105,167,267,309],"that":[5,34,342],"line":[6],"bile":[7,44],"ducts":[8],"and":[9,49,57,60,110,119,144,199,220,225,244,257,270,279,291,299,306],"play":[10],"a":[11,36,94,115,125,328],"central":[12,75],"role":[13,76],"as":[14,93,209,211],"the":[15,62,74,84,213,252,304,317,321],"site":[16],"of":[17,77,117,165,204,216,239,251,265,320,323],"injury":[18,51],"in":[19,29,70,79,108,128,132,152,183,189,234,303,327],"primary":[20],"biliary":[21],"cholangitis":[22],"(PBC).":[23],"The":[24],"Phase":[25],"3":[26],"RESPONSE":[27],"trial":[28],"patients":[30],"with":[31,67,157,168,207,268,311],"PBC":[32,80],"demonstrated":[33],"seladelpar,":[35],"selective":[37,324],"peroxisome":[38],"proliferator\u2013activated":[39],"receptor-delta":[40],"(PPAR\ud835\udeff)":[41],"agonist,":[42],"reduced":[43,302],"acid":[45,191],"pools,":[46],"improved":[47],"cholestatic":[48],"liver":[50],"markers":[52],"(alkaline":[53],"phosphatase,":[54],"gamma-glutamyl":[55],"transpeptidase,":[56],"alanine":[58],"aminotransferase),":[59],"decreased":[61],"pruritogenic":[63],"cytokine":[64],"interleukin":[65],"(IL)-31,":[66],"accompanying":[68],"improvement":[69],"patient-reported":[71],"pruritus.":[72],"Given":[73],"cholangiocytes":[78],"pathobiology,":[81],"we":[82],"examined":[83],"human":[85,292,329],"cholangiocyte":[86,330],"H69":[87,104,166,235,262,266,308],"cellular":[88],"response":[89,233],"to":[90,112,134],"seladelpar":[91,113,170,177,205,269,337],"treatment":[92,206,229],"potential":[95],"translational":[96],"model":[97],"for":[98],"its":[99],"observed":[100],"clinical":[101],"profile.":[102],"Methods:":[103],"were":[106,130,139,155,301],"cultured":[107],"vitro":[109],"exposed":[111],"at":[114],"range":[116],"concentrations":[118,208],"times.":[120],"Inflammatory":[121],"mediators,":[122],"including":[123,186,237],"IL-17,":[124],"known":[126],"mediator":[127],"cholangiopathy,":[129],"used":[131],"addition":[133],"seladelpar.":[135],"Gene":[136],"expression":[137,174,215],"changes":[138],"analyzed":[140,156],"by":[141,223,261],"bulk":[142],"RNAseq":[143],"quantitative":[145],"polymerase":[146],"chain":[147],"reaction":[148],"assays.":[149,162],"Secreted":[150],"cytokines":[151,253],"culture":[153],"media":[154],"Meso":[158],"Scale":[159],"Discovery":[160],"(MSD)":[161],"Results:":[163],"Treatment":[164],"10\u00b5M":[169],"induced":[171,230],"robust":[172],"gene":[173,214],"changes.":[175],"Notably,":[176],"significantly":[178],"upregulated":[179],"several":[180],"genes":[181,281,287,296],"important":[182],"lipid":[184],"pathways,":[185],"those":[187],"involved":[188],"fatty":[190],"\u03b2-oxidation:":[192],"ANGPTL4,":[193,221],"CPT1A,":[194],"ACADVL,":[195],"HADHA,":[196],"HADHB,":[197],"ACAA2,":[198],"ECH1.":[200],"After":[201],"22":[202],"hours":[203],"low":[210],"10nM,":[212],"PPAR\ud835\udeff-activated":[217],"genes,":[218],"PDK4":[219],"increased":[222],"4-":[224],"8-fold,":[226],"respectively.":[227],"IL-17":[228,271,312],"an":[231],"inflammatory":[232,340],"cells,":[236],"upregulation":[238],"CXCL10,":[240],"CCL5,":[241],"CXCL8,":[242],"CXCL1,":[243,289],"IL-6.":[245],"MSD":[246],"assays":[247],"confirmed":[248],"IL-17-induced":[249],"secretion":[250],"IL-6,":[254],"IL-8,":[255],"IL-1\u03b2,":[256],"Tumor":[258],"Necrosis":[259],"Factor-\u03b1":[260],"cells;":[263],"cotreatment":[264],"attenuated":[272],"this":[273],"IL-17\u2013induced":[274],"response.":[275],"Interferon":[276],"(IFN)-\u03b2-,":[277],"IFN-\u03bb-,":[278],"IFN-stimulated":[280],"(IFIT1,":[282],"ISG15,":[283],"RSAD2,":[284],"CXCL10);":[285],"chemokine":[286],"(CCL5,":[288],"CCL20);":[290],"leukocyte":[293],"antigen":[294],"(HLA)":[295],"(HLA-F,":[297],"HLA-E":[298],"HLA-DPB1)":[300],"seladelpar-":[305],"IL-17\u2013cotreated":[307],"compared":[310],"alone.":[313],"Conclusion:":[314],"This":[315],"is":[316],"first":[318],"report":[319],"effects":[322],"PPAR\ud835\udeff":[325],"activation":[326],"cell":[331],"line.":[332],"These":[333],"initial":[334],"results":[335],"suggest":[336],"modulated":[338],"multiple":[339],"mediators":[341],"need":[343],"further":[344],"study.":[345]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-10-25T00:00:00"}